A Long-tem Efficacy, Safety, and Tolerability Study of BOTOX in Patients With Chronic Migraine

Trial Profile

A Long-tem Efficacy, Safety, and Tolerability Study of BOTOX in Patients With Chronic Migraine

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2018

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Acronyms COMPEL
  • Sponsors Allergan
  • Most Recent Events

    • 28 Jun 2018 According to Allergan Media release, data from this trial will be presented at the American Headache Society's 60th Annual Scientific Meeting.
    • 27 Apr 2018 Results of a subanalysis assessing the effects of onabotulinumtoxinA prevention on comorbid sleep disturbances and fatigue symptoms, presented at the 70th Annual Meeting of the American Academy of Neurology.
    • 27 Apr 2018 Results of psychiatric comorbidities responder analysis (anxiety and depression) in patients with chronic migraine, presented at the 70th Annual Meeting of the American Academy of Neurology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top